These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18074111)
1. Association of polymorphism in the thermolabile 5, 10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Alam MA; Husain SA; Narang R; Chauhan SS; Kabra M; Vasisht S Mol Cell Biochem; 2008 Mar; 310(1-2):111-7. PubMed ID: 18074111 [TBL] [Abstract][Full Text] [Related]
2. An MTHFR variant, plasma homocysteine levels and late-onset coronary artery disease in subjects from southern Iran. Saffari B; Senemar S; Karimi M; Bahari M; Jooyan N; Yavarian M Pak J Biol Sci; 2013 Aug; 16(16):788-95. PubMed ID: 24498831 [TBL] [Abstract][Full Text] [Related]
3. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes. Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656 [TBL] [Abstract][Full Text] [Related]
4. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345 [TBL] [Abstract][Full Text] [Related]
5. The communal relation of MTHFR, MTR, ACE gene polymorphisms and hyperhomocysteinemia as conceivable risk of coronary artery disease. Masud R; Baqai HZ Appl Physiol Nutr Metab; 2017 Oct; 42(10):1009-1014. PubMed ID: 28514598 [TBL] [Abstract][Full Text] [Related]
6. The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Chao CL; Tsai HH; Lee CM; Hsu SM; Kao JT; Chien KL; Sung FC; Lee YT Atherosclerosis; 1999 Dec; 147(2):379-86. PubMed ID: 10559524 [TBL] [Abstract][Full Text] [Related]
7. Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity. Rassoul F; Richter V; Hentschel B; Geisel J; Herrmann W; Kuntze T Indian J Med Res; 2008 Feb; 127(2):154-8. PubMed ID: 18403793 [TBL] [Abstract][Full Text] [Related]
8. Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. Gupta SK; Kotwal J; Kotwal A; Dhall A; Garg S Indian J Med Res; 2012 Apr; 135(4):506-12. PubMed ID: 22664498 [TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal). Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842 [TBL] [Abstract][Full Text] [Related]
10. Association of the methylene-tetrahydrofolate reductase gene rs1801133 C677T variant with serum homocysteine levels, and the severity of coronary artery disease. Bouzidi N; Hassine M; Fodha H; Ben Messaoud M; Maatouk F; Gamra H; Ferchichi S Sci Rep; 2020 Jun; 10(1):10064. PubMed ID: 32572074 [TBL] [Abstract][Full Text] [Related]
11. Hyperhomocystinemia in patients with coronary artery disease. Faria-Neto JR; Chagas AC; Bydlowski SP; Lemos Neto PA; Chamone DA; Ramirez JA; da Luz PL Braz J Med Biol Res; 2006 Apr; 39(4):455-63. PubMed ID: 16612468 [TBL] [Abstract][Full Text] [Related]
12. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients. Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344 [TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. Kölling K; Ndrepepa G; Koch W; Braun S; Mehilli J; Schömig A; Kastrati A Am J Cardiol; 2004 May; 93(10):1201-6. PubMed ID: 15135689 [TBL] [Abstract][Full Text] [Related]
14. The effect of polymorphisms of MTHER gene and vitamin B on hyperhomocysteinemia. Chen J; Zhang I; Cheng L; Li Y J Tongji Med Univ; 2001; 21(1):17-20. PubMed ID: 11523237 [TBL] [Abstract][Full Text] [Related]
15. Gene-environment and gene-gene interactions of specific MTHFR, MTR and CBS gene variants in relation to homocysteine in black South Africans. Nienaber-Rousseau C; Ellis SM; Moss SJ; Melse-Boonstra A; Towers GW Gene; 2013 Nov; 530(1):113-8. PubMed ID: 23954866 [TBL] [Abstract][Full Text] [Related]
16. The role of methylenetetrahydrofolate reductase C677T gene polymorphism as a risk factor for coronary artery disease: a cross-sectional study in the Sidoarjo Regional General Hospital. Sugijo H; Sargowo D; Widjajanto E; Romdoni R Pan Afr Med J; 2022; 41():212. PubMed ID: 35721657 [TBL] [Abstract][Full Text] [Related]
17. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes. Hermans MP; Gala JL; Buysschaert M Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562 [TBL] [Abstract][Full Text] [Related]
18. Association between Li ZC; Huang M; Yao QY; Lin CH; Hong BC; Wang JH; Zhang Z J Integr Neurosci; 2024 Jan; 23(1):3. PubMed ID: 38287840 [TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in cervical artery dissection: a meta-analysis. Luo H; Liu B; Hu J; Wang X; Zhan S; Kong W Cerebrovasc Dis; 2014; 37(5):313-22. PubMed ID: 24903192 [TBL] [Abstract][Full Text] [Related]
20. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Nakai K; Itoh C; Nakai K; Habano W; Gurwitz D Am J Cardiovasc Drugs; 2001; 1(5):353-61. PubMed ID: 14728017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]